| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
12:00 to 12:18 | Are we about to abandon transplantation in diffuse large B-cell lymphoma? | Speaker |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
14:05 to 14:23 | Why should I worry about the complexity of CAR-T if bispecifics are coming around and it’s just a matter of prescribing them? | Speaker |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
14:30 to 15:00 | Round table: how to extract the best from conjugated or unconjugated monoclonal antibodies, chemotherapies, bispecific antibodies, and CAR-T in lymphomas? | Discussant |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
12:18 to 12:25 | Q&A | Discussant |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
13:15 to 13:33 | Moving beyond R-CHOP: how disease features can guide treatment in diffuse large B-cell lymphoma | Speaker |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
13:33 to 13:40 | Q&A | Discussant |
| 20/05/2023 | 12:00 to 15:00 | Di Cavalcanti |
Medical Medical Aggressive Lymphomas |
14:23 to 14:30 | Q&A | Discussant |